Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Leukemia, Published online: 25 October 2023; doi:10.1038/s41375-023-02042-4Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Source: Leukemia - October 25, 2023 Category: Hematology Authors: Arend v. Stackelberg Katja J äschke Etienne Jousseaume Corinna Templin Ulli Jeratsch Daniela Kosmides Ingo Steffen Nicola G ökbuget Christina Peters Source Type: research